Table 2.
Effectiveness of Guideline Implementation Systems
Study | Methodology | Documentation | Adherence | Satisfaction | Outcomes |
---|---|---|---|---|---|
Bouhaddou et al.12 | Time series without external control | Improved; indication of surgery | Improved; rate of request for surgery, mixed; increased preauthorization approval rate | Improved | Cost increased |
Burack et al.13 | RCT by patient | Nd | Increased use of mammography in health department setting, but not in HMO setting | Nd | Nd |
Burack and Gimotty14 | |||||
Day et al.15 | Time series without external control | Improved after-care instructions | No effect | Nd | No effect on cost |
Dexter et al.16 | RCT by provider team | Nd | Increased discussion with intervention (24% vs. 4% without) | Nd | Improved rate of advance directive completion, 4% vs. 15% |
Goethe et al.18 | Time series without external control | Nd | Improved response to alerts | Nd | Nd |
Litzelman et al.19 | RCT by provider team | Nd | Improved mammography and fecal occult blood testing; no effect on Pap testing | Nd | Nd |
Lobach and Hammond20 | RCT by clinician | Nd | Two-fold increase in compliance with guidelines for 3 of 8 standards; failure for 5 of 8 | Nd | Nd |
Margolis et al.21 | Time series without external control | Improved; 3 of 6 diseases | Improved for 2 of 6 diseases; decreased inappropriate use of antibiotics for 2 diseases | Too tedious, physicians refused to continue | Nd |
Nilasena et al.22 | RCT by physician | Nd | Improved average total compliance score for both control and intervention | 70% found forms difficult to use and did not reduce time to provide care | Nd |
Nilasena and Lincoln23 | |||||
Ornstein et al.25 | Time series without external control | Nd | Improved compliance with counseling, screening tests, breast exams, and thyroid function tests; no change for immunizations, fecal occult blood, Pap smear, mammography | No improvement in patient's perceived preventive services delivery | Nd |
Overhage et al.26 | RCT by provider team | Nd | No effect: control, 24% compliance rate; intervention, 23% | Nd | Nd |
Robbins et al.27 | Time series without external control | Nd | Nd | Nd | Cholesterol, LDL, and triglycerides levels decreased; HDL increased |
Rossi and Every28 | RCT by provider | Nd | Improved: 11.3% of patients changed to first line antihypertensive drugs | Nd | No significant change in BP |
Safran et al.29 | RCT by site | Nd | Improved: response time to alerts, 52 vs. 11 days | Nd | No change in admission rates, ER visits, survival or pneumocystis admissions |
Schriger et al.30 | Time series with switchback | Improved for 6 of 7 history items | Improved: 4 laboratory tests; 4 of 5 treatments | Nd | Cost: charges decreased for laboratory and prescriptions |
Tape and Campbell31 | Nonrandomized controlled trial by provider team | Nd | Improved sigmoidoscopy and immunization rates; no change in thyroxine, Pap, mammography, fecal occult blood screening | Nd | Nd |
Turner et al.32 | RCT by physician | Nd | Small improvement in health maintenance activities | Nd | Nd |
Vincent et al.33 | Time series without external control | Nd | Improved provider compliance; patient compliance improved for some | Nd | Nd |
Willson et al.34 | Time series without external control | Nd | Improved for both prevention and treatment protocols | Nd | Decrease in incidence of pressure ulcers |
Zielstorff et al.36 |
Time series with control |
Nd |
No effect: clinical decision making |
Positive for instructional adequacy and user satisfaction |
Nd |
Note: BP indicates blood pressure; Nd, not discussed; HDL, high-density lipoprotein; LDL, low-density lipoprotein; RCT, randomized controlled trial. |